NanoTalks by Curapath is your gateway to the future of healthcare nanotechnology. In each episode, we explore the latest trends in lipid and polymer nanoparticles a groundbreaking field transforming how next-generation therapies and vaccines are developed. Discover how these tiny, multifunctional structures can enhance treatment effectiveness, minimize side effects, and open the door to innovations that once seemed out of reach. Join us as we delve into cutting-edge research, clinical insights, and the major advances shaping modern medicine
Hot topics
NanoTalks
LNPs or PNPs that's the question
Discover the key differences between LNPs and PNPs and why payload type is only one factor in platform selection
This article explores how lipid and polymeric nanoparticles differ in composition, delivery performance, regulatory pathways, and manufacturability. You'll learn the main trade-offs between established LNP technologies and the broader design flexibility of PNPs, helping you identify the most suitable platform for a specific therapeutic strategy.
Keep exploring Curapath Blog , there is more NanoTalks yet to explore
Recent Articles
Lipid nanoparticles (LNPs) and polymeric nanoparticles (PNPs) are two leading non-viral drug delivery platforms. While...
Historically polymer excipients have been described as inactive formulation components. In today's drug delivery...
.png)
Polymers play a wide variety of rolesin today´s pharmaceutical landscape. They are used as excipients, drug delivery...
-1.jpg)
In polymer–drug conjugates, the polymer is not only a passive carrier. Its chemistry, molecular weight, architecture,...
.png)
Active targeting has emerged as one of the most promising strategies to unlock extrahepatic delivery of nanoparticles,...
.png)
The outcome of this step directly defines critical quality attributes, including: Particle size Polydispersity index...
.png)
Polymeric excipients play a critical role in modern therapeutic systems being a fundamental partin advanced and highly...
.png)
Medical device–associated infections remain a major challenge across healthcare, especially for catheters, orthopedic...
.jpg)
Polymer–drug conjugates (PDCs) represents a unique strategy in modern drug delivery: instead of encapsulating a drug...
Lipid–polymer hybrid nanoparticles (LPHNs) are emerging as one of the most promising platforms in nanomedicine....